Century Aluminum Company
NASDAQ:CENXAluminum
-$1.11 today
- Market cap
- $3.14B
- Beta
- 1.92
- P/E (TTM)
- 15.1
- EPS (TTM)
- $3.53
Volume 1.41M
Average 1.92M
CENX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Century Aluminum CompanyNASDAQ: CENX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CENX compares with its peers on the latest reported figures
- CENX's LTM Sep 2026 research & development of $0 is the lowest of the 4 companies compared; the peer median is $53M.
- Research & development amounts to 0.0% of revenue for CENX, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $101.2M | +59.6% | — | 2.4% | |
| LTM Sep 2026 | $53M | — | +6.1% | 0.5% | |
| LTM Sep 2026 | $18M | -65.4% | -9.1% | 0.1% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CENX) | $53M | -2.9% | -1.5% | 0.5% | |
Competitors are the stored peer set for CENX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.21B | 2.78B | 2.19B | 2.22B | 2.53B |
| Cost of Revenue | 2.09B | 2.73B | 2.09B | 2.04B | 2.27B |
| Gross Profit | 124.2M | 46.7M | 91.9M | 185M | 256.4M |
| Gross Margin | 5.6% | 1.7% | 4.2% | 8.3% | 10.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.6M | 37.5M | 44.3M | 56.8M | 79.9M |
| Operating Expenses | 58.2M | 196.9M | 60.1M | 63.6M | 98.3M |
| Depreciation & Amortization | 82.6M | 73.4M | 74.7M | 81.8M | 91.8M |
| EBITDA | (84.6M) | 136.1M | 43.4M | 448.7M | 142.2M |
| EBITDA Margin | -3.8% | 4.9% | 2.0% | 20.2% | 5.6% |
| Operating Income | 66M | (150.2M) | 31.8M | 121.4M | 158.1M |
| Operating Margin | 3.0% | -5.4% | 1.5% | 5.5% | 6.3% |
| Interest Income | 800K | 500K | 2M | 2.1M | 9.2M |
| Interest Expense | 30.4M | 29.3M | 35.5M | 43.1M | 47.7M |
| Other Income / Expenses | (263.7M) | 183.5M | (98.7M) | 202.5M | (155.4M) |
| Income Before Tax | (197.7M) | 33.3M | (66.9M) | 323.9M | 2.7M |
| Pre-Tax Margin | -8.9% | 1.2% | -3.1% | 14.6% | 0.1% |
| Income Tax Expense | (30.6M) | 47.4M | (14.6M) | 3.2M | (13.1M) |
| Net Income | (167.1M) | (14.1M) | (43.1M) | 336.8M | 41.8M |
| Net Margin | -7.6% | -0.5% | -2.0% | 15.2% | 1.7% |
| EPS (Basic) | (1.85) | (0.15) | (0.47) | 3.46 | 0.42 |
| EPS (Diluted) | (1.85) | (0.15) | (0.47) | 3.29 | 0.42 |
| Weighted Avg Shares | 90.2M | 91.4M | 92.4M | 92.8M | 94.2M |
| Weighted Avg Shares (Diluted) | 90.2M | 91.4M | 92.4M | 98.4M | 95.3M |
Century Aluminum Company
NASDAQ:CENX
Intrinsic Alpha fair value
Locked
Current Price
$31.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.